Brain Cancer clinical trials

Explore recruiting brain cancer clinical trials.

Recruiting brain cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Brain Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open label, Phase IV study to assess immunological changes in patients with glioblastoma multiforme treated with bevacizumab infusion

Hungary

Therapeutic use (Phase IV) EU CTIS Study details

FIREFLY-1: A Phase 2, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of the Oral Pan-RAF Inhibitor DAY101 in Pediatric Patients with RAF-Altered, Recurrent or Progressive Low-Grade Glioma and Advanced Solid Tumors

Denmark, Netherlands, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blind, placebo-controlled adjuvant trial in newly diagnosed primary glioblastoma subjects to assess the efficacy and safety of 2-hydroxyoleic acid (2-OHOA) in combination with radiotherapy and temozolomide standard of care treatment.

Spain, France, Italy

Phase II and Phase III (Integrated) EU CTIS Study details

A phase II study assessing safety and efficacy of REPotrectinib in ROS1-positive non-small cell lung cancer patients with active brain mEtastasis (The REPOSE study)

Germany, Spain, Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Study to evaluate the addition of an experimental drug, CC-90010, to the usual treatment of brain cancer after surgery

Denmark, Sweden, Spain, Italy, Norway, Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

A multicenter, open-label, non-comparative, single-arm, phase II trial of datopotamab deruxtecan for non-squamous non-small cell lung cancer patients with active brain metastases (The TUXEDO-5 Study)

Spain, Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Brain Cancer trials by city

Brain Cancer in Toronto Brain Cancer in Vancouver Brain Cancer in Montreal Brain Cancer in Calgary Brain Cancer in Edmonton Brain Cancer in Ottawa Brain Cancer in Winnipeg Brain Cancer in Quebec City Brain Cancer in Hamilton Brain Cancer in Kitchener Brain Cancer in London Brain Cancer in Halifax Brain Cancer in New York Brain Cancer in Los Angeles Brain Cancer in Chicago Brain Cancer in Houston

Brain Cancer clinical trials

Recruiting brain cancer studies right now

Neurocognition After Radiotherapy in CNS- and Skull-base Tumors

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital

FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients

a Feasibility Study of iHD-SRT for BM

Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases

4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma

The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy

Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Cancer

Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis

Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients

Also recruiting in Europe

An open label, Phase IV study to assess immunological changes in patients with glioblastoma multiforme treated with bevacizumab infusion

FIREFLY-1: A Phase 2, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of the Oral Pan-RAF Inhibitor DAY101 in Pediatric Patients with RAF-Altered, Recurrent or Progressive Low-Grade Glioma and Advanced Solid Tumors

A randomized, double-blind, placebo-controlled adjuvant trial in newly diagnosed primary glioblastoma subjects to assess the efficacy and safety of 2-hydroxyoleic acid (2-OHOA) in combination with radiotherapy and temozolomide standard of care treatment.

A phase II study assessing safety and efficacy of REPotrectinib in ROS1-positive non-small cell lung cancer patients with active brain mEtastasis (The REPOSE study)

Study to evaluate the addition of an experimental drug, CC-90010, to the usual treatment of brain cancer after surgery

A multicenter, open-label, non-comparative, single-arm, phase II trial of datopotamab deruxtecan for non-squamous non-small cell lung cancer patients with active brain metastases (The TUXEDO-5 Study)

Brain Cancer trials by city

Other conditions

Brain Cancer clinical trials

Recruiting brain cancer studies right now

Neurocognition After Radiotherapy in CNS- and Skull-base Tumors

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital

FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients

a Feasibility Study of iHD-SRT for BM

Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases

4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma

The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy

Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Cancer

Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis

Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients

Also recruiting in Europe

An open label, Phase IV study to assess immunological changes in patients with glioblastoma multiforme treated with bevacizumab infusion

FIREFLY-1: A Phase 2, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of the Oral Pan-RAF Inhibitor DAY101 in Pediatric Patients with RAF-Altered, Recurrent or Progressive Low-Grade Glioma and Advanced Solid Tumors

A randomized, double-blind, placebo-controlled adjuvant trial in newly diagnosed primary glioblastoma subjects to assess the efficacy and safety of 2-hydroxyoleic acid (2-OHOA) in combination with radiotherapy and temozolomide standard of care treatment.

A phase II study assessing safety and efficacy of REPotrectinib in ROS1-positive non-small cell lung cancer patients with active brain mEtastasis (The REPOSE study)

Study to evaluate the addition of an experimental drug, CC-90010, to the usual treatment of brain cancer after surgery

A multicenter, open-label, non-comparative, single-arm, phase II trial of datopotamab deruxtecan for non-squamous non-small cell lung cancer patients with active brain metastases (The TUXEDO-5 Study)

Brain Cancer trials by city

Other conditions

A phase II study assessing safety and efficacy of REPotrectinib in ROS1-positive non-small cell lung cancer patients with active brain mEtastasis (The REPOSE study)